Lars C. Petersen

Lars C. Petersen

Auto-generated profile, based on publicly available information

Lars C. Petersen

From the Department of Tissue Factor/Factor VIIa (TF/VIIa) Research, Health Care Discovery, Novo Nordisk A/S, Maalov, Denmark, and the Department of Biochemistry, the University of Texas Health Center at Tyler, TX

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1998 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LPLars K. Poulsen
Lars K. Poulsen
NJNana Jacobsen
Nana Jacobsen
BSBrit B. Sørensen
Brit B. Sørensen
NBNils C. H. Bergenhem
Nils C. H. Bergenhem
JKJames D. Kelly
James D. Kelly
LPLars C. Petersen
Lars C. Petersen
The putative role of tissue factor (TF) as a receptor involved in signal transduction is indicated by its sequence homology to cytokine receptors (Bazan, J. F. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 6934–6938). Signal transduction induced by binding of FVIIa to cells expressing TF was studied with baby hamster kidney (BHK) cells stably transfected with TF and with a reporter gene construct encoding a luciferase gene under transcriptional control of tandem cassettes of signal transducer and activator of transcription (STAT) elements and one serum response element (SRE). FVIIa induced a significant luciferase response in cells expressing TF, BHK(+TF), but not in cells without TF. The BHK(+TF) cells responded to the addition of FVIIa in a dose-dependent manner, whereas no response was observed with active site-inhibited FVIIa, which also worked as an antagonist to FVIIa-induced signaling. Activation of the p44/42 MAPK pathway upon binding of FVIIa to TF was demonstrated by suppression of signaling with the specific kinase inhibitor PD98059 and demonstration of a transient p44/42 MAPK phosphorylation. No stimulation of p44/42 MAPK phosphorylation was observed with catalytically inactive FVIIa derivatives suggesting that the catalytic activity of FVIIa was obligatory for activation of the MAPK pathway. Signal transduction caused by a putative generation of FXa activity was excluded by experiments showing that FVIIa/TF-induced signaling was not quenched by tick anticoagulant protein, just as addition of FXa could not induce phosphorylation of p44/42 MAPK in BHK(+TF) cells. These results suggest a specific mechanism by which binding of FVIIa to cell surface TF independent of coagulation can modulate cellular functions and possibly play a role in angiogenesis and tumor metastasis as indicated by several recent observations.

1 July 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BSBrit B. Sørensen
Brit B. Sørensen
PFPer-Ola Freskgård
Per-Ola Freskgård
LNLars Søegaard Nielsen
Lars Søegaard Nielsen
LRL. Vijaya Mohan Rao
L. Vijaya Mohan Rao
MEMirella Ezban
Mirella Ezban
LPLars C. Petersen
Lars C. Petersen
Signal transduction induced by activated factor VII (FVIIa) was studied with baby hamster kidney (BHK) cells transfected with human tissue factor (TF). FVIIa induced phosphorylation of p44/42 mitogen-activated protein kinase (MAPK) in cells expressing TF, BHK(+TF), but not in wild-type BHK(-TF) cells. BHK(+TF) cells responded to FVIIa in a dose-dependent manner, with detectable phosphorylation above 10–20 nm FVIIa. BHK cells transfected with a cytoplasmic domain-deleted version of TF, (des248–263)TF, or a C245S substitution variant of TF also supported FVIIa-induced MAPK activation. Experiments with active site-inhibited FVIIa, thrombin, factor Xa, and hirudin confirmed that the catalytic activity of FVIIa was mandatory for p44/42 MAPK activation. Furthermore, a high concentration of FVIIa in complex with soluble TF induced p44/42 MAPK phosphorylation in BHK(-TF) cells. These data suggest that TF was not directly involved in FVIIa-induced p44/42 MAPK phosphorylation but rather served to localize the action of FVIIa to the cell surface, potentially to cleave a cell surface receptor. Desensitization experiments with sequential addition of proteases suggested that the p44/42 MAPK response induced by FVIIa was distinctly different from the thrombin response, possibly involving a novel member of the protease-activated receptor family.

1 April 1997 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
LPLars C. Petersen
Lars C. Petersen
The two zymogens, plasminogen and pro‐urokinase plasminogen activator (pro‐uPA), constitute a system of reciprocal activation, since plasmin, generated by uPA‐catalysed plasminogen activation, can activate pro‐uPA to uPA. Two such zymogens, when mixed, will undergo autocatalytic, reciprocal activation resulting in generation of proteolytic activity. As an example of reciprocal zymaogen activation, the plasminogen/pro‐uPA system was analysed in terms of a kinetic model which describes the progression in activated enzymes. This model gave a detailed description of the progress curves in plasmin and uPA. It accounted for the effects of varying the concentration of the zymogens, and also for the effects of plasmin substrates and inhibitors in the reaction mixture. The model assumes non‐significant zymogen activity. It did not, however, exclude that a very low initial proteolytic activity, accounting for maximally 0.01% of that obtained when pro‐uPA is fully activated, could be attributed to a genuine pro‐uPA activity. Binding of the uPA receptor (uPAR) to pro‐uPA/uPA might affect separate steps of the reciprocal activation reaction, or it might induce a significant pro‐uPA activity. To distinguish between these possibilities the effect of a recombinant soluble (residues 1–277) form of uPAR, uPAR‐(1–277)‐peptide, on reciprocal pro‐uPA/plasminogen activation was studied. uPAR‐(1–277)‐peptide attenuated reciprocal zymogen activation, and the results suggested that this was due to a decreased accessibility of the pro‐uPA/uPAR‐(1–277)‐peptide complex to activation by plasmin. The uPAR‐(1–277)‐peptide in the presence of poly(D‐lysine) caused a 20‐fold enhancement of reciprocal zymogen activation. Kinetic analysis of separate activation steps revealed that this was due to a threefold stimulation of plasminogen activation by uPA/uPAR‐(1–277)‐peptide combined with a sixfold stimulation of plasmin's activation of pro‐uPA/uPAR‐(1–277)‐peptide. The results suggested that poly(D‐lysine) provided a template for a catalytically favourable interaction between plasminogen/plasmin and the uPAR‐(1–277)‐peptide complex with pro‐uPA/uPA. There was no indication of a significant uPAR‐(1–277)‐peptide‐induced enhancement of pro‐uPA activity.

1 January 2000 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
OTOle Thastrup
Ole Thastrup
GHGrith Hagel
Grith Hagel
BSBrit B. Sørensen
Brit B. Sørensen
PFPer-Ola Freskgård
Per-Ola Freskgård
LRL. Vijaya M. Rao
L. Vijaya M. Rao
LPLars C. Petersen
Lars C. Petersen
The protease activity is mandatory for intracellular activities induced by coagulation factor VIIa (FVIIa), and in this way it resembles signal transduction induced by thrombin and trypsin caused by specific, proteolytic cleavage of protease activated receptors (PARs). The mechanism for FVIIa-induced signal transduction is, however, not known although a mechanism involving PAR cleavage has been deduced from studies of cytosolic Ca2+ release and p44/p42 mitogen activated protein kinase (MAPK) activation. In the present work we have examined the possibilities that i) FVIIa-induced signal transduction involves the activation of one of the four known PARs, or ii) exposure of cells to FVIIa releases a soluble ligand that is responsible for MAPK activation. For this purpose, we evaluated the effects of FVIIa, thrombin, FXa, trypsin and PAR agonist peptides on the Ca2+ release and MAPK activation in tissue factor-(TF) transfected baby hamster kidney (BHK[+TF]) cells and Madin-Darby canine kidney (MDCK) cells. FVIIa induced a significant MAPK signal in BHK(+TF) cells and in MDCK-I and -II cells whereas no MAPK activation was observed with thrombin, FXa or PAR agonist peptides. Thrombin, trypsin, PAR-1 and PAR-2 agonist peptides induced a prominent Ca2+ response in both cell types. In contrast the cells did not respond with a detectable Ca2+ signal when treated with FVIIa. These results suggest that the intracellular activity induced by FVIIa is distinctly different from that induced by trypsin, thrombin and FXa not involving any of the known PARs. Conditioned medium from BHK(+TF) cells treated with FVIIa failed to induce a MAPK response in untreated BHK(+TF) cells when FVIIa was removed by immunoadsorption from the medium prior to its transfer to the untreated BHK(+TF) cells. Although it is not possible entirely to exclude a transient response close to the cell surface, the data suggest that the intracellular response was not induced by an autocrine release of a soluble mediator to the medium.

15 March 2001 in Blood
Verified
Journal Article
Open access
CHCarsten B. Hansen
Carsten B. Hansen
CPCharles Pyke
Charles Pyke
LPLars C. Petersen
Lars C. Petersen
LRL. Vijaya Mohan Rao
L. Vijaya Mohan Rao
Endocytosis and recycling of coagulation factor VIIa (VIIa) bound to tissue factor (TF) was investigated in baby hamster kidney (BHK) cells stably transfected with TF or TF derivatives. Cell surface expression of TF on BHK cells was required for VIIa internalization and degradation. Approximately 50% of cell surface–bound VIIa was internalized in one hour, and a majority of the internalized VIIa was degraded soon thereafter. Similar rates of VIIa internalization and degradation were obtained with BHK cells transfected with a cytoplasmic domain-deleted TF variant or with a substitution of serine for cysteine at amino acid residue 245 (C245S). Endocytosis of VIIa bound to TF was an active process. Acidification of the cytosol, known to inhibit the internalization via clathrin-coated pits, did not affect the internalization of VIIa. Furthermore, receptor-associated protein, known to block binding of all established ligands to members of the low-density lipoprotein receptor family, was without an effect on the internalization of VIIa. Addition of tissue factor pathway inhibitor/factor Xa complex did not affect the internalization rate significantly. A substantial portion (20% to 25%) of internalized VIIa was recycled back to the cell surface as an intact and functional protein. Although the recycled VIIa constitutes to only approximately 10% of available cell surface TF/VIIa sites, it accounts for 65% of the maximal activation of factor X by the cell surface TF/VIIa. In summary, the present data provide evidence that TF-dependent internalization of VIIa in kidney cells occurs through a clathrin-independent mechanism and does not require the cytoplasmic domain of TF.

1 January 2000 in Protein Science
Verified
Journal Article
Open access
PDF file
LPLars C. Petersen
Lars C. Petersen
PÅPer‐Ola Freskg Ård
Per‐Ola Freskg Ård
EPEgon Persson
Egon Persson
OOOle H. Olsen
Ole H. Olsen
LNLars S. Nielsen
Lars S. Nielsen
The protease domain of coagulation factor VIIa (FVIIa) is homologous to trypsin with a similar active site architecture. The catalytic function of FVIIa is regulated by allosteric modulations induced by binding of divalent metal ions and the cofactor tissue factor (TF). To further elucidate the mechanisms behind these transformations, the effects of Zn2+ binding to FVIIa in the free form and in complex with TF were investigated. Equilibrium dialysis suggested that two Zn2+ bind with high affinity to FVIIa outside the N‐terminal y‐carboxyglutamic acid (Gla) domain. Binding of Zn2+ to FVIIa, which was influenced by the presence of Ca2+, resulted in decreased amidolytic activity and slightly reduced affinity for TF. After binding to TF, FVIIa was less susceptible to zinc inhibition. Alanine substitutions for either of two histidine residues unique for FVIIa, His216, and His257, produced FVIIa variants with decreased sensitivity to Zn2+ inhibition. A search for putative Zn2+ binding sites in the crystal structure of the FVIIa protease domain was performed by Grid calculations. We identified a pair of Zn2+ binding sites in the Glu210–Glu220 Ca2+ binding loop adjacent to the so‐called activation domain canonical to serine proteases. Based on our results, we propose a model that describes the conformational changes underlying the Zn2+‐mediated allosteric down‐regulation of FVIIa's activity.